Addition of MPS-II to the Recommended Uniform Screening Panel in the United States

David S Millington; Can Ficicioglu

doi:10.3390/ijns8040055

Addition of MPS-II to the Recommended Uniform Screening Panel in the United States

Int J Neonatal Screen. 2022 Oct 11;8(4):55. doi: 10.3390/ijns8040055.

Authors

David S Millington¹, Can Ficicioglu^{2

3}

Affiliations

¹ Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC 27709, USA.
² Section of Biochemical Genetics, Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
³ Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Abstract

It has recently been announced that the Secretary of the U.S. Department of Health and Human Services has approved the recommendation by the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) to add mucopolysaccharidosis type II (MPS-II, Hunter Syndrome) to the recommended uniform screening panel (RUSP) in the United States [...].

Publication types

Editorial